AbbVie Q4 Earnings Review: I May Have Just Made A Huge Mistake

分组1 - Edmund Ingham is a biotech consultant with over 5 years of experience in covering biotech, healthcare, and pharma sectors [1] - He has compiled detailed reports on more than 1,000 companies and leads the investing group Haggerston BioHealth [1] - Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts, buy and sell ratings, product sales forecasts, and integrated financial statements [1] 分组2 - The group conducts discounted cash flow analysis and market-by-market analysis for major pharmaceutical companies [1]